← Leaderboards
Arthur Roger Strauch
Ohio State University
$3,442,644
Attributed
$3,442,644
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–12$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$4,736,923 · 5
By mechanism
R01$2,661,491 · 2
P01$1,922,932 · 2
R03$152,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Arthur H.m Burghes$13,366,018
- Sashwati Roy$8,043,268
- Jacob Yount$9,023,802
Others in their field
Top investigators on “Fibrosis”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Peter Scott Heeger · Case Western Reserve University$58,406,959
- John F Engelhardt · University Of Iowa$51,265,353
- David Albert Schwartz · Va Eastern Colorado Health Care System$41,842,857
- Richard C Boucher · University Of North Carolina Chapel Hill$33,165,173
- Bruce A. Stanton · Dartmouth College$32,494,343
Research focus
FibrosisWound HealingCardiac MyocytesTissuesPromotor (Genetics)Signal TransductionVascular Smooth MuscleMyofibroblastMolecularMediatingOutputPhosphotransferasesBaseProteinsComplexFibroblastsGene ExpressionTranscription CoactivatorAffectLaboratory MouseLungCell TypeDesignImmunocytochemistry
Grant awards (15)
Peri-arteriolar Myofibroblast Differentiation in the Pathobiology of IPAH$76,250
R03 · FY2012 · HL · contact PI
Targeting myofibroblast activation in chronic fibrotic disease$375,000
R01 · FY2011 · HL · contact PI
Peri-arteriolar Myofibroblast Differentiation in the Pathobiology of IPAH$76,250
R03 · FY2011 · HL · contact PI
Targeting myofibroblast activation in chronic fibrotic disease$375,000
R01 · FY2010 · HL · contact PI
Targeting myofibroblast activation in chronic fibrotic disease$375,000
R01 · FY2009 · HL · contact PI
Targeting myofibroblast activation in chronic fibrotic disease$15,780
R01 · FY2009 · HL · contact PI
Targeting myofibroblast activation in chronic fibrotic disease$375,000
R01 · FY2008 · HL · contact PI
Mechanisms of Chronic Pathobiology in Allografts$1,294,279
P01 · FY2005 · HL
Myofibroblasts and fibrosis after cardiac transplant$323,569
P01 · FY2005 · HL
TRANSCRIPTIONAL BASIS OF CARDIAC ALLOGRAFT REMODELING$287,611
R01 · FY2003 · HL
Myofibroblasts and fibrosis after cardiac transplant$305,084
P01 · FY2002 · HL
TRANSCRIPTIONAL BASIS OF CARDIAC ALLOGRAFT REMODELING$285,180
R01 · FY2002 · HL
TRANSCRIPTIONAL BASIS OF CARDIAC ALLOGRAFT REMODELING$293,713
R01 · FY2001 · HL
Myofibroblasts and fibrosis after cardiac transplant$0
P01 · FY2001 · HL
TRANSCRIPTIONAL BASIS OF CARDIAC ALLOGRAFT REMODELING$279,207
R01 · FY2000 · HL